
Aptose Biosciences Investor Relations Material
Latest events

EGM 2024
Aptose Biosciences
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Aptose Biosciences Inc
Access all reports
Aptose Biosciences Inc. is a clinical-stage biotechnology company focused on developing targeted therapies for hematologic malignancies, including leukemia, lymphoma, and myeloma. The company leverages innovative approaches in small-molecule drug design to address unmet medical needs in cancer treatment. The company is headquartered in Toronto, Canada, and its shares are listed on the NASDAQ.
Latest articles
)
Robert G. Hagstrom: Darwinian Investing and Multidisciplinary Wisdom
Robert G. Hagstrom, author of The Warren Buffett Way, explores how interdisciplinary thinking shapes his investing, from Adler's reading to Darwinian markets.
7 Feb 2025
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Ticker symbol
APTO
Country
🇺🇸 United States